Specific Biologics Inc. to Present Dualase® Genome Editing for the Precise Removal of Pathogenic Repeats in Repeat Expansion Disorders at the 28th Annual American Society for Gene and Cell Therapy Meeting
TORONTO, May 6, 2025 /PRNewswire/ - Specific Biologics Inc., a biotechnology company advancing industry leading genome editing therapies, today announced...